142 related articles for article (PubMed ID: 8380161)
1. Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.
Cory AH; Shibley IA; Chalovich JM; Cory JG
J Biol Chem; 1993 Jan; 268(1):405-9. PubMed ID: 8380161
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine.
Cory JG; Nelson TO; Somerville L; Cory AH
Adv Enzyme Regul; 1997; 37():3-16. PubMed ID: 9381977
[TBL] [Abstract][Full Text] [Related]
3. Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.
Cory AH; Cory JG
Adv Enzyme Regul; 1994; 34():1-12. PubMed ID: 7942266
[TBL] [Abstract][Full Text] [Related]
4. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
Cory AH; Hertel LW; Kroin JS; Cory JG
Oncol Res; 1993; 5(2):59-63. PubMed ID: 8364254
[TBL] [Abstract][Full Text] [Related]
5. Distinct sites for deoxyguanosine and deoxyadenosine phosphorylation on a monomeric kinase from Lactobacillus acidophilus.
Chakravarty R; Ikeda S; Ives DH
Biochemistry; 1984 Dec; 23(25):6235-40. PubMed ID: 6098313
[TBL] [Abstract][Full Text] [Related]
6. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.
Sarup JC; Fridland A
Biochemistry; 1987 Jan; 26(2):590-7. PubMed ID: 3030413
[TBL] [Abstract][Full Text] [Related]
7. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
Cory AH; Samano V; Robins MJ; Cory JG
Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
Zhu C; Johansson M; Permert J; Karlsson A
Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
[TBL] [Abstract][Full Text] [Related]
9. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
10. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
11. Human placental deoxyadenosine and deoxyguanosine phosphorylating activity.
Hurley MC; Palella TD; Fox IH
J Biol Chem; 1983 Dec; 258(24):15021-7. PubMed ID: 6317685
[TBL] [Abstract][Full Text] [Related]
12. Deoxyadenosine/deoxycytidine kinase from Bacillus subtilis. Purification, characterization, and physiological function.
Møllgaard H
J Biol Chem; 1980 Sep; 255(17):8216-20. PubMed ID: 6251049
[TBL] [Abstract][Full Text] [Related]
13. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
[TBL] [Abstract][Full Text] [Related]
14. High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity.
Veselý J
Neoplasma; 1987; 34(6):713-20. PubMed ID: 2448662
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver.
Lewis RA; Link L
Biochem Pharmacol; 1989 Jun; 38(12):2001-6. PubMed ID: 2545209
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2'-deoxycytidine: modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Antiviral Res; 1991 May; 15(4):301-13. PubMed ID: 1659312
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
18. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794
[TBL] [Abstract][Full Text] [Related]
19. Purine ribonucleoside and deoxyribonucleoside kinase activities in thymocytes. Specificity and optimal assay conditions for phosphorylation.
Lukey T; Snyder FF
Can J Biochem; 1980 Sep; 58(9):677-82. PubMed ID: 6257352
[TBL] [Abstract][Full Text] [Related]
20. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Mancini WR
Cancer Chemother Pharmacol; 1992; 30(2):139-44. PubMed ID: 1318170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
